Xospata (Gilteritinib Tablet) 40mg

Xospita 40mg tablets contain gilteritinib, a prescription medication used for certain blood conditions. It belongs to a class of drugs that work by affecting the growth of cancer cells. This overview covers general information about its use and handling.

Strength

40mg

Pack Size

90s

Storage

Ambient

Manufacturer / TM Owner

Astellas USA Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Gilteritinib is primarily used to treat adults with a specific type of blood cancer, such as acute myeloid leukemia (AML) with certain genetic changes. It is prescribed when the cancer has come back or has not responded to prior treatments. Patients often ask what gilteritinib is used for, and it is indicated for relapsed or refractory AML with FLT3 mutations.

Side Effects

This medication works by targeting specific pathways involved in the growth of cancer cells, helping to slow or stop their spread. Many patients notice changes in their energy levels and overall well-being while taking it. It is not a cure but may help manage the condition over time.

Precautions & Warnings

Store gilteritinib tablets at room temperature away from moisture and heat. Keep the medication in its original packaging until ready to use. Always handle with clean, dry hands and avoid splitting or crushing the tablets unless instructed by a healthcare provider.

Avoid Interactions

Certain medications, including some antibiotics and antifungals, may interact with gilteritinib. Avoid grapefruit products, as they can affect how the drug works. Alcohol and herbal supplements should be used cautiously; consult a healthcare professional before combining with other substances.

Frequently Asked Questions

Gilteritinib is used to treat adults with relapsed or refractory acute myeloid leukemia (AML) that has a specific genetic mutation.

Store at room temperature in a dry place, away from direct light and out of reach of children.

Do not split or crush the tablets unless directed by a healthcare professional.

Avoid grapefruit products and consult your doctor before taking any new medications or supplements.

Gilteritinib is not a cure but may help manage the condition in some patients with specific genetic mutations.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.